Population-based screening for rare mutations: High-throughput DNA extraction and molecular amplification from Guthrie cards

被引:40
作者
Hamvas, A
Trusgnich, M
Brice, H
Baumgartner, J
Hong, YL
Nogee, LM
Cole, FS
机构
[1] St Louis Childrens Hosp, Div Newborn Med, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Edward Mallinckrodt Dept Pediat, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA
[4] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21287 USA
[5] Missouri Dept Hlth, Jefferson City, MO 65102 USA
关键词
D O I
10.1203/00006450-200111000-00021
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
To determine the population-based frequency of a rare mutation (the 121ins2 mutation in the surfactant protein B gene), we developed high-throughput techniques to extract reliably and rapidly amplifiable DNA from Guthrie cards. Using a 3-mm punch from each of 10,044 Guthrie cards obtained from, the Missouri Department of Health, we extracted DNA with deionized water by heating in the presence of 2% Chelex in a 96-well format. Average yield of DNA from each punch was 52.6 +/- 21 mug. Using 36mer primers and a 10-muL reaction volume, we amplified a 354-bp fragment of the surfactant protein B gene that contained the mutation and identified the mutation by its susceptibility to restriction enzyme digestion with SfuI The procedure required 5 h per 96 samples but only 2 h of technician time. The amplification rate on the first attempt was 99.2%. Based on detection of eight individuals heterozygous for the mutation (confirmed by direct sequencing), we estimate the allele frequency to be 0.8/1000 individuals, an estimate not significantly different from previous estimates based on independent methods. High-throughput DNA extraction and amplification will permit establishment of DNA banks as well as efficient estimation of population-based genotype frequency for both rare and common genetic disorders.
引用
收藏
页码:666 / 668
页数:3
相关论文
共 24 条
[1]  
AKANE A, 1994, J FORENSIC SCI, V39, P362
[2]  
CARDUCCI C, 1992, BIOTECHNIQUES, V13, P735
[3]   Population-based estimates of surfactant protein B deficiency [J].
Cole, FS ;
Hamvas, A ;
Rubinstein, P ;
King, E ;
Trusgnich, M ;
Nogee, LM ;
deMello, DE ;
Colten, HR .
PEDIATRICS, 2000, 105 (03) :538-541
[4]  
DelRio SA, 1996, BIOTECHNIQUES, V20, P970
[5]   Heterozygosity for the common LCHAD mutation (1528G>C) is not a major cause of HELLP syndrome and the prevalence of the mutation in the Dutch population is low [J].
Den Boer, MEJ ;
Ijlst, L ;
Wijburg, FA ;
Oostheim, W ;
Van Werkhoven, MA ;
Van Pampus, MG ;
Heymans, HSA ;
Wanders, RJA .
PEDIATRIC RESEARCH, 2000, 48 (02) :151-154
[6]   Analysis of 31 CFTR mutations by polymerase chain reaction oligonucleotide ligation assay in a pilot screening of 4476 newborns for cystic fibrosis [J].
Gasparini, P ;
Arbustini, E ;
Restagno, G ;
Zelante, L ;
Stanziale, P ;
Gatta, L ;
Sbaiz, L ;
Sedita, AM ;
Banchieri, N ;
Sapone, L ;
Fiorucci, GC ;
Brinson, E ;
Shulse, E ;
Rappaport, E ;
Fortina, P .
JOURNAL OF MEDICAL SCREENING, 1999, 6 (02) :67-69
[7]  
Hamvas A, 1997, Curr Probl Pediatr, V27, P325, DOI 10.1016/S0045-9380(97)80028-X
[8]   Hyaline membrane disease is underreported in a linked birth-infant death certificate database [J].
Hamvas, A ;
Kwong, P ;
DeBaun, M ;
Schramm, W ;
Cole, FS .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1998, 88 (09) :1387-1389
[9]  
Makowski GS, 1998, ANN CLIN LAB SCI, V28, P380
[10]  
Makowski GS, 1997, J CLIN LAB ANAL, V11, P87, DOI 10.1002/(SICI)1098-2825(1997)11:2<87::AID-JCLA4>3.0.CO